Research programme: glucocorticoid receptor modulators - Abbott/Ligand
Latest Information Update: 17 Nov 2006
At a glance
- Originator Abbott Laboratories; Ligand Pharmaceuticals
- Mechanism of Action Glucocorticoid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Inflammation